Showing 1 - 10 of 21
Persistent link: https://www.econbiz.de/10003375041
Persistent link: https://www.econbiz.de/10000901603
Persistent link: https://www.econbiz.de/10001104366
Persistent link: https://www.econbiz.de/10001585673
Several antitrust cases have involved allegations of anticompetitive innovation or product design and some plaintiffs and antitrust scholars have argued that investment in research and development that excludes competition can have predatory effects similar to predatory pricing. This article...
Persistent link: https://www.econbiz.de/10014050519
A proposal for moving from price-centric to innovation-centric competition policy, reviewing theory and evidence on economic incentives for innovation. Competition policy and antitrust enforcement have traditionally focused on prices rather than innovation. Economic theory shows the ways that...
Persistent link: https://www.econbiz.de/10013465592
A number of antitrust cases have challenged firm conduct associated with the introduction of a new product. Several are in the pharmaceutical industry and have earned the moniker of “product hopping.” Other cases involve the design of interfaces that defeat interoperability and the supply of...
Persistent link: https://www.econbiz.de/10013001957
Licensing promotes technology transfer and innovation, but enforcement of licensing contracts is often imperfect. We model contract enforcement as a game with perfect information but probabilistic enforcement and explore the implications of weak enforcement on the design of licensing contracts,...
Persistent link: https://www.econbiz.de/10012971957
Antitrust cases, including recent complaints filed against dominant technology platforms, have alleged conduct that harms innovation. Section 2 of the Sherman Act is sufficiently broad to address conduct that harms innovation, but courts have little experience adjudicating such allegations. This...
Persistent link: https://www.econbiz.de/10013234840
Persistent link: https://www.econbiz.de/10014434493